Intuitive Surgical [ISRG] vs Alcon [ALC] Detailed Stock Comparison
Intuitive Surgical
NASDAQ
Loading...
Alcon
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Intuitive Surgical wins in 12 metrics, Alcon wins in 7 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Intuitive Surgical | Alcon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 67.08 | 40.84 | Alcon |
| Price-to-Book Ratio | 9.65 | 2.07 | Alcon |
| Debt-to-Equity Ratio | 0.00 | 23.63 | Intuitive Surgical |
| PEG Ratio | 2.76 | 26.11 | Intuitive Surgical |
| EV/EBITDA | 52.40 | 21.16 | Alcon |
| Profit Margin (TTM) | 28.51% | 11.28% | Intuitive Surgical |
| Operating Margin (TTM) | 30.47% | 13.30% | Intuitive Surgical |
| EBITDA Margin (TTM) | 30.47% | 13.30% | Intuitive Surgical |
| Return on Equity | 16.04% | 5.23% | Intuitive Surgical |
| Return on Assets (TTM) | 9.02% | 2.74% | Intuitive Surgical |
| Free Cash Flow (TTM) | $1.30B | $1.41B | Alcon |
| 1-Year Return | 0.27% | -7.32% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 18.83 | 4.62 | Alcon |
| Enterprise Value | $166.94B | $49.36B | Intuitive Surgical |
| EV/Revenue Ratio | 18.26 | 4.97 | Alcon |
| Gross Profit Margin (TTM) | 66.31% | 55.92% | Intuitive Surgical |
| Revenue per Share (TTM) | $26 | $20 | Intuitive Surgical |
| Earnings per Share (Diluted) | $7.16 | $2.25 | Intuitive Surgical |
| Beta (Stock Volatility) | 1.60 | 0.70 | Alcon |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Intuitive Surgical vs Alcon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 0.67% | 2.17% | -6.24% | -14.28% | -20.08% | -8.35% |
| Alcon | 1.06% | 2.29% | 2.05% | 0.05% | -1.95% | 5.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 0.27% | 113.66% | 107.64% | 752.73% | 1,372.74% | 5,693.24% |
| Alcon | -7.32% | 27.36% | 49.65% | 61.14% | 61.14% | 61.14% |
Performance & Financial Health Analysis: Intuitive Surgical vs Alcon
| Metric | ISRG | ALC |
|---|---|---|
| Market Information | ||
| Market Cap | $172.16B | $45.84B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,853,870 | 1,498,680 |
| 90 Day Avg. Volume | 2,048,940 | 1,604,603 |
| Last Close | $480.26 | $87.71 |
| 52 Week Range | $425.00 - $616.00 | $80.48 - $101.10 |
| % from 52W High | -22.04% | -13.24% |
| All-Time High | $616.00 (Jan 20, 2025) | $101.10 (Sep 09, 2024) |
| % from All-Time High | -22.04% | -13.24% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.01% |
| Quarterly Earnings Growth | 0.25% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.11% |
| Operating Margin (TTM) | 0.30% | 0.13% |
| Return on Equity (TTM) | 0.16% | 0.05% |
| Debt to Equity (MRQ) | 0.00 | 23.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $49.79 | $44.39 |
| Cash per Share (MRQ) | $14.86 | $2.85 |
| Operating Cash Flow (TTM) | $2.83B | $2.12B |
| Levered Free Cash Flow (TTM) | $1.82B | $1.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Intuitive Surgical vs Alcon
| Metric | ISRG | ALC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 67.08 | 40.84 |
| Forward P/E | 61.10 | 26.11 |
| PEG Ratio | 2.76 | 26.11 |
| Price to Sales (TTM) | 18.83 | 4.62 |
| Price to Book (MRQ) | 9.65 | 2.07 |
| Market Capitalization | ||
| Market Capitalization | $172.16B | $45.84B |
| Enterprise Value | $166.94B | $49.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 18.26 | 4.97 |
| Enterprise to EBITDA | 52.40 | 21.16 |
| Risk & Other Metrics | ||
| Beta | 1.60 | 0.70 |
| Book Value per Share (MRQ) | $49.79 | $44.39 |
Financial Statements Comparison: Intuitive Surgical vs Alcon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ISRG | ALC |
|---|---|---|
| Revenue/Sales | $2.44B | $2.47B |
| Cost of Goods Sold | $822.10M | $1.09B |
| Gross Profit | $1.62B | $1.38B |
| Research & Development | $313.30M | $222.00M |
| Operating Income (EBIT) | $743.40M | $468.00M |
| EBITDA | $898.70M | $463.00M |
| Pre-Tax Income | $832.10M | $414.00M |
| Income Tax | $167.90M | $64.00M |
| Net Income (Profit) | $664.20M | $350.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ISRG | ALC |
|---|---|---|
| Cash & Equivalents | $2.57B | $1.41B |
| Total Current Assets | $7.66B | $6.07B |
| Total Current Liabilities | $1.54B | $2.25B |
| Long-Term Debt | N/A | $5.02B |
| Total Shareholders Equity | $17.21B | $22.02B |
| Retained Earnings | $7.14B | N/A |
| Property, Plant & Equipment | N/A | $4.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ISRG | ALC |
|---|---|---|
| Operating Cash Flow | $833.10M | N/A |
| Capital Expenditures | $-116.60M | N/A |
| Free Cash Flow | $465.00M | $384.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ISRG | ALC |
|---|---|---|
| Shares Short | 4.30M | 6.89M |
| Short Ratio | 2.18 | 4.54 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 1,853,870 | 1,498,680 |
| Average Daily Volume (90 Day) | 2,048,940 | 1,604,603 |
| Shares Outstanding | 356.60M | 494.62M |
| Float Shares | 356.33M | 494.60M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.89% | 0.69% |
Dividend Analysis & Yield Comparison: Intuitive Surgical vs Alcon
| Metric | ISRG | ALC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.17 |
| 3-Year Avg Dividend Yield | N/A | 0.30% |
| 3-Year Total Dividends | N/A | $0.50 |
| Ex-Dividend Date | N/A | May 14, 2024 |